Product Information
RANOLAZINE ER 1,000 MG TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.2757 per EA under NDC 63304001860. Its NADAC has been published 340 times since Aug 21, 2019.
FDA first approved this application on May 28, 2019.
The Low Outlier badge above means this manufacturer's average price in the Ranolazine market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1000 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
63304001860
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
RANOLAZINEApproval Type
Generic (ANDA)
FDA Application
ANDA211707FDA Approved
5/28/2019
On Market Since
5/28/2019
Pharmacological Classes
Price Statistics
The NADAC for RANOLAZINE ER 1,000 MG TABLET has been published 340 times since Aug 21, 2019, and over the history we have for it it has declined 76.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2757 per EA |
|---|---|
| All-time high | $1.1472 (Oct 16, 2019) |
| All-time low | $0.2757 (Feb 18, 2026) |
| 52-week high | $0.3159 |
| 52-week low | $0.2757 |
| Median price | $0.3668 |
| Average price | $0.5145 |
| Largest weekly change | -21.2% (Mar 23, 2022) |
| Weeks tracked | 340 |
| Tracking since | Aug 21, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-12.7%
3Y
-15.8%
5Y
-57.9%
All
-76.0%
Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RANOLAZINE ER 1,000 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RANOLAZINE ER 1,000 MG TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $0.2757 per EA (NDC 63304001860), effective Feb 18, 2026.
How has the price of RANOLAZINE ER 1,000 MG TABLET changed over time?
Over the history we have for it, the NADAC for RANOLAZINE ER 1,000 MG TABLET has declined 76.0%. It has been tracked across 340 weekly CMS publications since Aug 21, 2019.
What are the highest and lowest recorded NADAC prices for RANOLAZINE ER 1,000 MG TABLET?
Since Aug 21, 2019, the NADAC for RANOLAZINE ER 1,000 MG TABLET has ranged from a low of $0.2757 (Feb 18, 2026) to a high of $1.1472 (Oct 16, 2019), with a median of $0.3668 per EA.
Are there cheaper alternatives to RANOLAZINE ER 1,000 MG TABLET?
11 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RANOLAZINE ER 1,000 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures RANOLAZINE ER 1,000 MG TABLET?
RANOLAZINE ER 1,000 MG TABLET (NDC 63304001860) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.